Crispr Therapeutics AG (CRSP)
NASDAQ · Healthcare
Crispr Therapeutics AG Cash on Hand 2015–2025
Crispr Therapeutics AG annual cash on hand history from 2015 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Crispr Therapeutics AG cash on hand as of December 31, 2025: 347.6M, a 16.53% increase year-over-year.
- Crispr Therapeutics AG cash on hand for 2025 were 347.6M, a 16.53% increase from 2024.
- Crispr Therapeutics AG cash on hand for 2024 were 298.3M, a 23.42% decrease from 2023.
- Crispr Therapeutics AG cash on hand for 2023 were 389.5M, a 83.82% increase from 2022.
- Crispr Therapeutics AG cash on hand for 2022 were 211.9M.
Cash on Hand
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Crispr Therapeutics AG Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $348 |
| 2024 | $298 |
| 2023 | $389 |
| 2022 | $212 |
| 2021 | $923 |
| 2020 | $1,169 |
| 2019 | $944 |
| 2018 | $457 |
| 2017 | $240 |
| 2016 | $316 |
| 2015 | $156 |
Crispr Therapeutics AG Cash on Hand — FAQ
Crispr Therapeutics AG (CRSP) cash on hand over the last 11 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CRSP's cash on hand history?
The chart and table above show Crispr Therapeutics AG's cash on hand by year and by quarter, including the growth rate.